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Abstract
Background: The mixed epithelial stromal tumour is morphologically characterised by a mixture
of solid and cystic areas consisting of a biphasic proliferation of glands admixed with solid areas of
spindle cells with variable cellularity and growth patterns. In previous reports the seminal vesicle
cystoadenoma was either considered a synonym of or misdiagnosed as mixed epithelial stromal
tumour. The recent World Health Organisation Classification of Tumours considered the two
lesions as two distinct neoplasms. This work is aimed to present the low-grade epithelial stromal
tumour case and the review of the literature to the extent of establishing the true frequency of the
neoplasm.
Case presentation: We describe a low-grade epithelial stromal tumour of the seminal vesicle in
a 50-year-old man. Computed tomography showed a 9 × 4.5 cm pelvic mass in the side of the
seminal vesicle displacing the prostate and the urinary bladder. Magnetic resonance was able to
define tissue planes between the lesion and the adjacent structures and provided useful information
for an accurate conservative laparotomic surgical approach. The histology revealed biphasic
proliferation of benign glands admixed with stromal cellularity, with focal atypia. After 26 months
after the excision the patient is still alive with no evidence of disease.
Conclusion: Cystoadenoma and mixed epithelial stromal tumour of seminal vesicle are two
distinct pathological entities with different histological features and clinical outcome. Due to the
unavailability of accurate prognostic parameters, the prediction of the potential biological evolution
of mixed epithelial stromal tumour is still difficult. In our case magnetic resonance imaging was able
to avoid an exploratory laparotomy and to establish an accurate conservative surgical treatment of
the tumour.
Background
The mixed epithelial and stromal tumour (MEST) is mor-
phologically characterised by a mixture of solid and cystic
areas with a biphasic proliferation of glands admixed with
solid areas of spindle cells, with variable cellularity and
growth patterns. We report a low grade MEST of the sem-
inal vesicle and we emphasize the diagnostic criteria and
the different diagnosis as cystoadenoma.
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Case presentation
A 50-year-old man was admitted in November 2005 to
our hospital with disuria, fever and gradual decrease in
urinary stream for several months. On ultrasound (US) a
hynomogeneous, hypoechoic pelvic mass of the posterior
side of the bladder was demonstrated. Abdominal com-
puted tomography (CT) revealed a 9 × 4.5 cm pelvic mass
in the side of the seminal vesicles displacing the prostate
and urinary bladder. On precontrast CT, the mass showed
fluid heterogeneous content, well-defined margins, and
irregular thin enhanced internal septa after intravenous
contrast material administration. On axial spin-echo T1-
weighted and axial and sagittal T2-weighted (Fig. 1a–c)
magnetic resonance imaging (MRI), a large well defined
multilocular pelvic mass was revealed in the side of the
seminal vesicles, contiguous to the posterior wall of the
urinary bladder, above the prostate and anterior to the rec-
tum. On T1 and T2-weighted images, the mass showed
internal septa that delimited heterogeneous iso- hyperin-
tense areas with proteinaceus content. On axial T1-
weighted fat-suppression gradient-echo images, before
and after intravenous administration of gadopentetate-
dimeglumine (gadolinium-DTPA), no enhancement of
the mass occurred. The exploratory laparotomy revealed a
retrovesical mass, which was well defined and not firmly
adherent anteriorly to the bladder. It was supposed that
the origin of the mass might be the right seminal vesicle.
The tumour was totally dissected from the attachments to
the bladder anteriorly ad rectum posteriorly, which
required the removal of the left seminal vesicle and a por-
tion of both vasa deferens. 14 months after surgery, the
patient is currently alive with no evidence of disease. The
tumour measured 9 × 6 × 6 cm and consisted of an oval
rubbery mass. The cut surfaces showed multilocular cysts
of variable sizes and shapes filled with gelatinous material
(Fig. 2). The histological examination revealed two dis-
tinctive but intermixed components, one glandular and
the other stromal (Fig. 3). The glandular proliferation was
characterized by cystically dilated glandular spaces, con-
taining pale eosinophilic intraluminal secretions and
lined by one to two layers of cuboidal or low columnar
cells. There was either no significant cytologic atypia or
appreciable mitotic activity. The epithelial cells were uni-
formly reactive against all keratin proteins (AE1/AE3,
CAM5.2, and high-molecular-weight keratin). Mono-
clonal and polyclonal carcinoembryonic antigen (CEA),
Axial spin-echo T1-weighted (a) and axial (b) and sagittal T2-weighted (c) MRI showed a large, well-defined, multilocular pelvic  mass in the side of the seminal vesicles, contiguous to the posterior wall of the urinary bladder and the prostate Figure 1
Axial spin-echo T1-weighted (a) and axial (b) and sagittal T2-weighted (c) MRI showed a large, well-defined, 
multilocular pelvic mass in the side of the seminal vesicles, contiguous to the posterior wall of the urinary blad-
der and the prostate. On T1 and T2-weighted images the mass showed internal septations that delimited heterogeneous 
iso- hyperintense areas with proteinaceus content.
The cut surface showed multilocular cists of varying size and  shapes Figure 2
The cut surface showed multilocular cists of varying 
size and shapes. The segments of both the right and the 
left vas deferens were evident. Inset: the external surface was 
yellow, smooth and glistening.World Journal of Surgical Oncology 2008, 6:101 http://www.wjso.com/content/6/1/101
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prostate acid phosphatase (PAP) and prostate – specific
antigen (PSA) stains gave negative results. The stromal
component was composed by extensive loosely cellular
areas with mixoid content. The stromal cells were spindle-
shaped and showed pleomorphism. The stroma was at
least focally densely cellular and tended to condense
around distorted glands. No mitoses were found (Fig. 4).
The spindle-shaped cells showed strong reactivity for
vimentin, CD34, and patchy weaker reactivity (30%) for
α-smooth muscle actin (Fig. 5a–c) and desmin, but were
negative for cytokeratin and PSA. We preferred a diagnosis
of low grade MEST because of the presence of cellular ple-
omorphism of the stromal component. 26 months after
surgery, the patient is still alive, with no evidence of dis-
ease.
Discussion
In our case the low-grade MEST diagnosis was made in
accordance with the World Health Organization (WHO)
classification criteria [1]. The lesion arose from the semi-
nal vesicle and did not: a) present normal tissue, b) invade
the prostate, and it was not immunoreactive for mono-
clonal and polyclonal CEA, PAP and PSA. The glandular
proliferation was benign. Mitosis and atypia of the epithe-
lium were not found. The stromal cellularity was mostly
pronounced in the tissue adjacent to intratumoural
glands. Focal cellular pleomorphism was present, but
mitoses were not found. The examined lesion was catego-
rized into low-grade MEST because of the presence of aty-
pia in the spindle-shaped cells. The former literature
reviews reported MEST under different names: cystomy-
oma [2], cystadenoma [3-12], mesonephric hamartoma
Microscopically the tumour showed cistically dilatated glands  containing pale eosinophilic intraluminal secretions and lined  by one to two layers of cuboidal or low columnar cells (H&E  ×40) Figure 3
Microscopically the tumour showed cistically dila-
tated glands containing pale eosinophilic intraluminal 
secretions and lined by one to two layers of cuboidal 
or low columnar cells (H&E ×40).
The stromal cells were spindle-shaped and showed pleomor- phism Figure 4
The stromal cells were spindle-shaped and showed 
pleomorphism. The stroma was at least focally densely cel-
lular and tended to condense around distorted glands (H&E 
×200).
The stromal cells show positivity for AML (a)(×400), Vimentin (b)(×600) and CD 34 (c)(×600) Figure 5
The stromal cells show positivity for AML (a)(×400), Vimentin (b)(×600) and CD 34 (c)(×600).W
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Table 1: Literature review of mixed epithelial and stromal tumour of seminal vesicle
Authors Years Presentation symptoms Radiological findings Surgical specimen/Treatment 
(symbol)
Histology/Follow up
Plaut et al (1944)^ 66. Asymptomatic Palpable mass in left 
lower abdominal quadrant
Not performed 14 × 11 × 8 cm mass connected to another 
8.5 × 6 × 6 cm mass by a pedicle-like 
structure/*
Cystomyoma/NED 5 months after surgery
Soule H et al (1951) 47. Fatigue, nocturia, rectal mass on 
physical examination
Not performed 14 × 6 × 6 cm cystic mass/* Cystoadenoma/Not reported
Kinas et al (1987) 63. Pelvic mass on physical examination Pelvic mass compressing extrinsically UB (IVP), displacing 
the rectosigmoid to the left and upwards (barium 
enema). CT: large, soft tissue density located on the 
posterolateral aspect of the UB. The UB and rectum 
were displaced toward the left side without signs of 
invasion
Not reported/* Mesonephric hamartoma/Not reported
Mazur et al (1987) 49. Acute urinary retention IVP: 7.5 × 5.0 cm mass indenting the posterior and 
interior aspect of the UB
7 × 5 × 2.5 cm cystic mass at the first 
operation and 8.5 × 7 × 7 cm cystic mass at 
the second exploration/*=
Cystic epithelial stromal tumor/Recurrence 
locally 2 years after the first excision. 
Ned.18 months after re-excision
Fain et al (1992) 61. Acute urinary retention CT: solid mass of high density in the region of the left SV 8 × 5 × 6.5 cm tan polypoid mass 
obliterating the left SV/°
Cystosarcoma phyllodes/Lung metastases 4 
years after resection
Laurila et al (1992) 49. Gradual decrease in urinary stream for 
several years
Large fluid filled mass in the lower abdomen (US) located 
directly superior to the prostate and dorsal to the UB 
replacing the right SV (CT)
6 ×5 × 5 cm cystic mass/° Müllerian adenosarcomalike tumour/NED 4 
years after surgery
Mazzuc-chelli et al (1992) 63. Intermittent increasing pain in the left 
inguinal area
IVP: left external compression of the UB 3 × 1.5 × 1 cm mass located within the left 
SV/*Ω
Cystoadenoma (benign fibroepithelial and 
cystic tumour)/NED 8 years after surgery
Baschinsky et al (1998) 37. Bladder outlet obstruction and 
hematospermia
CT: 6.2 × 6.2 cm mass of mixed attenuation located 
posterior to the UB and anterior to the rectum
6.5 ×5 × 3.5 cm tumour with a coarsely 
lobulated, almost cerebriform contour and a 
smooth, glistening, tan surface/°#
Cystoadenoma/NED 6 months after surgery
Santos et al (2001) 49. lower abdominal discomfort CT: 15 × 9.5 × 7 cm heterogeneous soft tissue density 
mass within the pelvis near the midline, situated in close 
proximity to the right of SV and anterior wall of the 
rectum
16 × 11 × 7 cm, well-circumscribed, oval, 
firm to rubbery solid-cystic mass/*
Cystoadenoma/Not reported
Abe et al (2002) 65. urinary hesitancy, frequency, and 
constipation
CT: 5.5 × 6 cm solid mass involving nearly the entire 
right SV, compressing the prostate to the left anterior 
side, but distinct from the prostate. IVP: compression of 
the UB to the left anterior side
Not reported Cystosarcoma phyllodes/lung metastasis 
seven months after surgery, death 11 
months after surgery
Gil et al (2003) 49. Asymptomatic CT-MRI: 9 cm well-defined expansive tumour, 
predominantly cystic, with septations, replacing the left 
SV
7 × 5 × 4.5 cm cystic mass/* Cystoadenoma/NED 3 years after surgery
Zanetti et al (2003) 62. Soft mass in the site of the left SV on 
rectal examination
US-CT: on the left retrovesical position presence of a 
cystic mass with a 2.5 cm solid tumour inside
Not reported/* Fibroepithelial tumour/NED (one year after 
surgery)
Son et al (2004) 39. Urinary retention and lower abdominal 
discomfort
CT: 14.5 × 12 cm heterogeneous soft tissue density mass 
located posterior to the UB and anterior to the rectum
16 × 13.5 × 8.5 cm tumour mass and a 5.1 × 
3.3 × 1.5 cm tissue separated from the base 
of the mass/*Ω
Phyllodes tumour/NED 12 months after 
surgery and radiotherapy
Hoshi et al (2006) 70. General fatigue, lower abdominal pain MRI: mass in the SV with a thin capsule of low-signal 
intensity; with compression of the prostate to the left 
anterior side but distinct from the prostate
4.5 cm in diameter, coarsely lobulated 
tumour with a smooth surface and 
surrounded by a thin fibrous capsule/°
Epithelial stromal tumour with phyllodes 
tumour-like features/NED 14 months after 
surgery
Lee et al (2006) 46. Asymptomatic Sagittal T2-wighted MRI: multiseptated cystic lesion with 
heterogeneous signal intensity, originating from the 
posterior region of the prostate and extending 
superiorly over the UB
7.5 × 7 × 6 cm, well-circumscribed, oval, 
rubbery and lobulated contour mass/@
Cystadenoma/NED 6 months after surgery
^ In the cystomyoma of Plaut and Standard it is unclear whether the epithelium is a component of the neoplasm or an entrapped native structure. For these reasons the neoplasm should not be considered 
as a true MEST.
Treatment: * tumorectomy Ω left vesciculectomy @ Removal tumour mass, left SV, portion of both right and left vas deferens ° radical cysto-prostatectomy # radical cystoprostatectomy and low anterior 
resection of the rectum. = tumorectomy, removal of a portion of the bladder, of both right and left vas deferens and rectal muscularis propria.
Legend: UB = Urinary bladder; NED = No evidence of disease; IVP = Excretory urography; US = Ultrasonography; SV = Seminal vesicle.World Journal of Surgical Oncology 2008, 6:101 http://www.wjso.com/content/6/1/101
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[13], papillary cystadenoma [14], cystic epithelial-stromal
tumour [15], mullerian adenosarcoma-like tumour [16],
cystosarcoma phyllodes [17,18], phyllodes tumour [19],
epithelial stromal tumour with phyllodes tumour-like fea-
tures [20], benign fibroepithelial tumour [21].
These tumours have been considered to represent mor-
phological variants of the same neoplasm, which may
reveal local recurrence but not malignant transformation
[7,10]. In the WHO classification [1], the seminal vesicle
cystoadenoma (SVC) was excluded from the category of
MESTs and considered as a distinct neoplasm; it should be
histologically distinguished from MEST by its non-neo-
plastic stroma. Consequently the previous reports of
MESTs have been critically revised (table 1). In the reviews
of 10 and 14 MESTs, Baschinsky et al., [9] and Son et al.,
[19] reported respectively 6 and 8 cases of SVC. According
to WHO criteria, the cases of SVC reported by Lagalla et al.,
[8], Bullock et al [6], Damjanov and Apic [22], Lundhus et
al., [23], should be excluded from MESTs. This is because
the description of stromal component is absent [6] or
because microscopically they showed a non-neoplastic
stromal component, that is typical of benign glandular
tumours. The SVC described by Soule and Dockerty [3],
Baschinky et al., [9], Mazzucchelli et al., [7], Gil et al., [11],
the mesonephric hamartoma of Kinas et al., [13], the
benign fibroepithelial of Zanetti et al., [20], should be
considered MEST, because all these tumours showed
simultaneous ductal and stromal proliferations. In the
histological grading of stromal component, the WHO
classification categorised MESTs in low or high grade,
depending on mitotic activity and necrosis [1]. But the
number of mitosis is not specified. In the high-grade
MEST the stroma should be at least focally densely cellular
and condensed around distorted glands. In the differen-
tial diagnosis between low and high-grade MEST the his-
tological features reported by WHO classification are not
exhaustive to achieve a conclusive diagnosis. The WHO
rejected the concept of phylloides tumour despite the evi-
dence that it is a separate entity from cystadenoma. In the
MEST review of Son et al., [19] and Hoshi et al., [20] the
classification of Baschinsky et al., [9] in low, intermediate,
high-grade MEST was reported. Surprisingly this distinc-
tion is not described in the original paper of Baschinsky et
al., [11]. In the description of cystosarcoma phyllodes,
Fain et al., [17] examined the tumours reported by Mazur
et al., [15] and Soule and Dockerty [3]: obviously the spec-
trum of phyllodes tumour reported by Fain et al., may be
not accepted as conclusive because only three cases were
considered. In our case US was only useful to detect the
lesion, but both its site and relations with adjacent organs
were not established. CT confirmed the presence, size,
location, internal consistency, extension of the primary
tumour, and the absence of distant metastases. MRI was
useful in establishing the tumour origin from the seminal
vesicles and its relations with the adjacent organs (Fig. 1).
MRI with fat-suppression and administration of paramag-
netic contrast agent is recommended to demonstrate the
absence of tumour vascularisation and to indicate the
benign non-vascular nature of the mass.
Conclusion
SVC and MEST are two distinct pathological entities with
different histological features and clinical outcome. Pre-
dicting the potential biological behaviour of MEST
remains difficult because accurate prognostic parameters
are not available. In our case MRI was able to avoid an
exploratory laparotomy and to establish an accurate con-
servative surgical treatment of the tumour.
List of abbreviations
MEST: mixed epithelial and stromal tumour; US: ultra-
sound; WHO: World Health Organization; CT: Computed
tomography; MRI: magnetic resonance imaging; CEA: car-
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PSA: prostate specific antigen.
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